Update on the COLIPA eye irritation programme for development of in vitro methods

被引：0

作者：

Jones, Penny ^{[1
]}

Bessou-Touya, Sandrine ^{[2
]}

Declercq, Lieve ^{[3
]}

De Smedt, Ann ^{[4
]}

De Wever, Bart ^{[5
]}

Faller, Claudine ^{[6
]}

Harbell, John ^{[7
]}

Le Varlet, Beatrice ^{[8
]}

McNamee, Pauline ^{[9
]}

Marrec-Fairley, Monique ^{[10
]}

Pape, Wolfgang ^{[11
]}

Pfannenbecker, Uwe ^{[11
]}

Schroeder, Klaus ^{[12
]}

Tailhardat, Magalie ^{[13
]}

Van den Berghe, Christine ^{[14
]}

Van Goethem, Freddy ^{[4
]}

机构：

[1] Safety & Environm Assurance Ctr, Sharnbrook, Beds, England

[2] Lab Pierre Fabre, Castres, France

[3] Estee Lauder Co, Oevel, Belgium

[4] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium

[5] Phenion, Frankfurt, Germany

[6] Cosmital SA, Procter & Gamble, Marly, Switzerland

[7] Mary Kay Inc, Dallas, TX USA

[8] Links Ingenierie, Paris, France

[9] Procter & Gamble Co, Surrey, England

[10] COLIPA, Brussels, Belgium

[11] Beiersdorf, Hamburg, Germany

[12] Henkel KGAA, Dusseldorf, Germany

[13] LVMH, St Jean De Braye, France

[14] LOreal, Aulnay Sous Bois, France

来源：

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL | 2008年 / 44卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S45 / S46

页数：2

共 50 条

[1] Update of the COLIPA eye irritation task force strategy and programme for development of in vitro methods
Le Varlet, B.
Alepee, N.
Bessou-Touya, S.
De Smedt, A.
De Wever, B.
Harbell, J.
Jones, P.
Mcnamee, P.
Marrec-Fairley, M.
Pfannenbecker, U.
Tailhardat, M.
Van Goethem, F.
TOXICOLOGY LETTERS, 2010, 196 : S143 - S144
[2] Assessment of the Cytosensor microphysiometer assay in the COLIPA in vitro eye irritation validation study
Harbell, JW
Osborne, R
Carr, GJ
Peterson, A
TOXICOLOGY IN VITRO, 1999, 13 (02) : 313 - 323
[3] Report on the COLIPA workshop on mechanisms of eye irritation
Bruner, LH
de Silva, O
Earl, LK
Easty, DL
Pape, W
Spielmann, H
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1998, 26 (06): : 811 - 820
[4] Evaluation of the EYTEX™ system in the COLIPA eye irritation program
Courtellemont, P
Pannetier, M
Biesse, JP
Larnicol, M
Baret, JP
Breda, B
TOXICOLOGY IN VITRO, 1999, 13 (02) : 295 - 304
[5] Assessment of the chorioallantoic membrane vascular assay (CAMVA) in the COLIPA in vitro eye irritation validation study
Bagley, DM
Cerven, D
Harbell, J
TOXICOLOGY IN VITRO, 1999, 13 (02) : 285 - 293
[6] Eye irritation hazard of chemicals and formulations assessed by methods in vitro
Jirova, Dagmar
Kejlova, Kristina
Janousek, Stanislav
Bendova, Hana
Maly, Marek
Kolarova, Hana
Dvorakova, Marketa
NEUROENDOCRINOLOGY LETTERS, 2014, 35 : 133 - 140
[7] COLIPA validation project on in vitro eye irritation tests for cosmetic ingredients and finished products (Phase I):: The red blood cell test for the estimation of acute eye irritation potentials.: Present status
Pape, WJW
Pfannenbecker, U
Argembeaux, H
Bracher, M
Esdaile, DJ
Hagino, S
Kasai, Y
Lewis, RW
TOXICOLOGY IN VITRO, 1999, 13 (02) : 343 - 354
[8] Relevance and reliability of the PREDISAFE assay in the COLIPA eye irritation validation program (Phase 1)
Courtellemont, P
Hébert, P
Biesse, JP
Castelli, D
Friteau, L
Serrano, J
Robles, C
TOXICOLOGY IN VITRO, 1999, 13 (02) : 305 - 312
[9] In Vitro Eye Irritation Testing
不详
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2018, 46 (05): : 250 - 250
[10] Are in vitro methods really useful for eye irritation assessment of children products?
Rocha, Bianca Fragoso
Queiroz, Diana
Fonseca, Vitor
Lucena, Kaline
Sa-Rocha, Vanessa
TOXICOLOGY LETTERS, 2013, 221 : S141 - S142

← 1 2 3 4 5 →